Widely Used Acid Reflux and Heartburn Medication Recalled Due to Findings of Cancer-Causing Substance
Zantac Recalled by FDA
The Food and Drug Administration (FDA) has requested manufacturers to withdraw all Zantac and generic ranitidine drugs from the market effective immediately after research showed findings of N-Nitrosodimethylamine (NDMA), a cancer-causing substance, in the drugs.
What is Ranitidine? (Brand Name Zantac)
Ranitidine is an H2 (histamine-2) blocker, that works by decreasing the amount of acid created by the stomach and therefore prevents and relives heartburn associated with acid indigestion. It is widely used as an over the counter treatment for heartburn and acid reflux, but is also prescribed for multiple indications including ulcers of the stomach and intestines, and the treatment of Zollinger-Ellison syndrome and gastroesophageal reflux disease (GERD).
Cancer-Causing Substance Found in Zantac
N-nitrosodimethylamine (NDMA) is a known carcinogen and can be found in trace amounts in water and foods including meat, dairy and vegetables. The FDA states that consuming up to 96 nanograms of NDMA per day is safe for humans. The FDA also stated that “...[S]ustained higher levels of exposure to NDMA may increase the risk of cancer in humans.”
The levels of NDMA found in ranitidine far exceeded the recommended daily amount safe for humans. It was also found that NDMA levels in some ranitidine products increase with time and temperature meaning that the temperature at which the product is stored and the longer the product sits on the shelf (whether in the store or in the home) can increase risk to consumers.
The FDA was first alerted of the NDMA exposure in September 2019 when a private pharmacy, Valisure, filed a Citizen’s Petition stating that their testing detected high levels of the carcinogen in Zantac and ranitidine products. Valisure found that in conditions designed to mimic breakdown in the stomach, levels of NDMA from Zantac may be 3,000 times higher than the FDA daily limit of 96 ng per day.
Details About the Zantac Lawsuit
A lawsuit has been filed on behalf of those people who have developed cancer as a result of taking Zantac. Plaintiffs claim that Zantac, and its generic counterparts, contain a dangerous quantity of NDMA and Zantac and other drug companies failed to warn consumers.
If you have taken Zantac or Ranitidine and Have Been Diagnosed with Cancer, You May Be Entitled to Compensation
Lawsuits are being reviewed nationwide for individuals who meet the following criteria:
- Used Zantac, Zantac OTC, or Generic Ranitidine;
- Exposed to the medication for at least 3 months; and
- Diagnosed with cancer of the Bladder, Stomach, Small Intestine, Colorectral, Esophageal, Liver, or Digestive Tract.
Common Zantac Brands and Generic Ranitidine Brands
- Ride Aid
- Wal-Zan® (Walgreens)
- Equate™ (Walmart)
- Heartburn Relief
- Acid Reducer
- Acid Control
When to Contact a Lawyer
Lawyers across the country are reviewing potential cases for people who feel that they or a loved one have been injured by use of Zantac and Ranitidine products. It is important to contact an experienced attorney immediately. Click here to find answer to common defective drug lawsuit questions.
Call Keller & Keller Today
At Keller & Keller, we have been protecting the rights of injured people—including those harmed by multi-billion dollar pharmaceutical companies—since 1936. Fill out our confidential free contact form on this page, or call us at 1-800-253-5537 for a free consultation with one of our attorneys.